MustGrow Biologics Corp. MGROF
OTC PK
| 06/30/2026 | 03/31/2026 | ||||
|---|---|---|---|---|---|
| Revenue | 1,351.26% | -88.48% | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | 1,351.26% | -88.48% | |||
| Cost of Revenue | 1.83% | -78.52% | |||
| Gross Profit | 1,374.36% | -81.87% | |||
| SG&A Expenses | 12.20% | -48.38% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | 4.19% | -58.39% | |||
| Operating Income | 162.27% | 38.56% | |||
| Income Before Tax | 146.97% | 57.80% | |||
| Income Tax Expenses | -- | -- | |||
| Earnings from Continuing Operations | 146.97% | 57.80% | |||
| Earnings from Discontinued Operations | 71.82% | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | 121.33% | 35.95% | |||
| EBIT | 162.27% | 38.56% | |||
| EBITDA | 164.24% | 38.85% | |||
| EPS Basic | 120.51% | 39.06% | |||
| Normalized Basic EPS | 145.31% | 38.46% | |||
| EPS Diluted | 120.51% | 39.06% | |||
| Normalized Diluted EPS | 145.31% | 38.46% | |||
| Average Basic Shares Outstanding | 3.12% | 5.14% | |||
| Average Diluted Shares Outstanding | 3.12% | 5.14% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||